|
gptkbp:instanceOf
|
gptkb:United_States_federal_law
|
|
gptkbp:affects
|
gptkb:Food_and_Drug_Administration
clinical trials
medical device
pharmacy compounding
dissemination of information on off-label uses
drug approval process
fast track drug approval
pediatric drug studies
|
|
gptkbp:amendedBy
|
gptkb:Federal_Food,_Drug,_and_Cosmetic_Act
|
|
gptkbp:citation
|
gptkb:111_Stat._2296
|
|
gptkbp:dateEnacted
|
November 21, 1997
|
|
gptkbp:enactedBy
|
gptkb:United_States_Congress
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Public Law 105-115
|
|
gptkbp:officialName
|
gptkb:Food_and_Drug_Administration_Modernization_Act_of_1997
|
|
gptkbp:publicLawNumber
|
105-115
|
|
gptkbp:purpose
|
to reform regulation of food, drugs, devices, and biological products
|
|
gptkbp:repealedBy
|
gptkb:Section_127_(pharmacy_compounding_provisions,_later_overturned_by_Supreme_Court)
|
|
gptkbp:shortName
|
gptkb:FDAMA
|
|
gptkbp:signedBy
|
gptkb:Bill_Clinton
|
|
gptkbp:statutesAtLargeCitation
|
gptkb:111_Stat._2296
|
|
gptkbp:title
|
gptkb:Food_and_Drug_Administration_Modernization_Act_of_1997
|
|
gptkbp:bfsParent
|
gptkb:Food_and_Drug_Administration_Modernization_Act
gptkb:Food_and_Drug_Administration_Modernization_Act_of_1997
|
|
gptkbp:bfsLayer
|
6
|